Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment

References

• Queiroz-Telles F, McGinnis MR, Salkin I, Graybill JR. Subcutaneous mycoses. Infect Dis Clin North Am 2003; 17: 59–85.
   PubMed Web of Science ®Google Scholar
• Pang KR, Wu JJ, Huang DB, Tyring SK. Subcutaneous fungal infections. Dermatologic Ther 2004; 17: 523–531.
   PubMedGoogle Scholar
• Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases [quiz]. J Am Acad Dermatol 2005; 53: 931–951.
   PubMed Web of Science ®Google Scholar
• Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. Clin Dermatol 2007; 25: 181–187.
   PubMed Web of Science ®Google Scholar
• Bustamante B, Campos PE. Endemic sporotrichosis. Curr Opin Infect Dis 2001; 14: 145–149.
   PubMed Web of Science ®Google Scholar
• Marimon R, Cano J, Gene J, . Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol 2007; 45: 3198–3206.
   PubMed Web of Science ®Google Scholar
• Bonifaz A, Vázquez-González D. Sporotrichosis: an update. G Ital Dermatol Venereol 2010; 145: 659–673.
   PubMed Web of Science ®Google Scholar
• Morris-Jones R. Sporotrichosis. Clin Exp Dermatol 2002; 27: 427–431.
   PubMed Web of Science ®Google Scholar
• Rodrigues MT, de Resende MA. Epidemiologic skin test survey of sensitivity to paracoccidioidin, histoplasmin and sporotrichin among gold mine workers of Morro Velho Mining, Brazil. Mycopathologia 1996; 135: 89–98.
   PubMed Web of Science ®Google Scholar
• Conti Diaz IA. Epidemiology of sporotrichosis in Latin America. Mycopathologia 1989; 108: 113–116.
   PubMed Web of Science ®Google Scholar
• Marimon R, Gene J, Cano J, . Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol 2006; 44: 3251–3256.
   PubMed Web of Science ®Google Scholar
• Mesa-Arango AC, Del Rocio Reyes-Montes M, Perez-Mejia A, . Phenotyping and genotyping of Sporothrix schenckii isolates according to geographic origin and clinical form of Sporotrichosis. J Clin Microbiol 2002; 40: 3004–3011.
   PubMed Web of Science ®Google Scholar
• Neyra E, Fonteyne PA, Swinne D, . Epidemiology of human sporotrichosis investigated by amplified fragment length polymorphism. J Clin Microbiol 2005; 43: 1348–1352.
   PubMed Web of Science ®Google Scholar
• Arenas R, Miller D, Campos-Macias P. Epidemiological data and molecular characterization (mtDNA) of Sporothrix schenckii in 13 cases from Mexico. Int J Dermatol 2007; 46: 177–179.
   PubMed Web of Science ®Google Scholar
• Ishizaki H, Kawasaki M, Aoki M, . Mitochondrial DNA analysis of Sporothrix schenckii in North and South America. Mycopathologia 1998; 142: 115–118.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Tellez I, Deep AE, . Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis 2000; 30: 65–70.
   PubMed Web of Science ®Google Scholar
• Lyon GM, Zurita S, Casquero J, . Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. Clin Infect Dis 2003; 36: 34–39.
   PubMed Web of Science ®Google Scholar
• da Rosa ACM, Scroferneker ML, Vettorato R, . Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol 2005; 52: 451–459.
   PubMed Web of Science ®Google Scholar
• Carvalho MT, de Castro AP, Baby C, . Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case. Rev Soc Bras Med Trop 2002; 35: 655–659.
   PubMedGoogle Scholar
• de Lima Barros MB, de Oliveira Schubach A, do Valle ACF, . Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis 2004; 38: 529–535.
   PubMed Web of Science ®Google Scholar
• de Lima Barros MB, Schubach TM, Galhardo MC, . Sporotrichosis: an emergent zoonosis in Rio de Janeiro. Mem Inst Oswaldo Cruz 2001; 96: 777–779.
   PubMed Web of Science ®Google Scholar
• Schubach A, Schubach TMP, de Lima Barros MB, Wanke B. Cat-transmitted sporotrichosis, Rio de Janeiro, Brazil. Emerg Infect Dis 2005; 11: 1952–1954.
   PubMed Web of Science ®Google Scholar
• de Lima Barros MB, de Oliveira Schubach A, Galhardo MCG, . Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol 2003; 42: 677–681.
   PubMed Web of Science ®Google Scholar
• Lopes JO, Alves SH, Mari CR, . [Epidemiology of sporotrichosis in the central region of Rio Grande do Sul]. Rev Soc Bras Med Trop 1999; 32: 541–545.
   PubMedGoogle Scholar
• Mendoza M, Diaz E, Alvarado P, . [Isolation of Sporothrix schenckii from environmental samples in Venezuela]. Rev Iberoam Micol 2007; 24: 317–319.
   PubMedGoogle Scholar
• Ahmed AO, van Leeuwen W, Fahal A, . Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 2004; 4: 566–574.
   PubMed Web of Science ®Google Scholar
• Cortez KJ, Roilides E, Quiroz-Telles F, . Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21: 157–197.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Adelmann D, Fahal A, . Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan. J Clin Microbiol 2002; 40: 1031–1036.
   PubMed Web of Science ®Google Scholar
• Rios-Fabra A, Moreno AR, Isturiz RE. Fungal infection in Latin American countries. Infect Dis Clin North Am 1994; 8: 129–154.
   PubMed Web of Science ®Google Scholar
• Poncio Mendes R, Negroni R, Bonifaz A, Pappagianis D. New aspects of some endemic mycoses. Med Mycol 2000; 38: 237–241.
   PubMed Web of Science ®Google Scholar
• Castro LGM, Belda Junior W, Salebian A, Cuce LC. Mycetoma: a retrospective study of 41 cases seen in Sao Paulo, Brazil, from 1978 to 1989. Mycoses 1993; 36: 89–95.
   PubMed Web of Science ®Google Scholar
• Castro LGM, Piquero-Casals J. Clinical and mycologic findings and therapeutic outcome of 27 mycetoma patients from Sao Paulo, Brazil. Int J Dermatol 2008; 47: 160–163.
   PubMed Web of Science ®Google Scholar
• Buot G, Lavalle P, Mariat F, Suchil P. [Epidemiologic study of mycetomas in Mexico. Apropos of 502 cases]. Bull Soc Pathol Exot Filiales 1987; 80: 329–339.
   PubMed Web of Science ®Google Scholar
• Lopez Martinez R, Mendez Tovar LJ, Lavalle P, . [Epidemiology of mycetoma in Mexico: study of 2105 cases]. Gac Med Mex 1992; 128: 477–481.
   PubMedGoogle Scholar
• Biagini RE, Martinez TE, Museli A, Sarmiento Villa H. [Mycetoma in northern Argentina]. Med Cutan Ibero Lat Am 1983; 11: 431–436.
   PubMedGoogle Scholar
• Negroni R, Lopez Daneri G, Arechavala A, Bianchi MH, Robles AM. [Clinical and microbiological study of mycetomas at the Muniz hospital of Buenos Aires between 1989 and 2004]. Rev Argent Microbiol 2006; 38: 13–18.
   PubMedGoogle Scholar
• Lopez Martinez R, Mendez Tovar LJ. Chromoblastomycosis. Clin Dermatol 2007; 25: 188–194.
   PubMed Web of Science ®Google Scholar
• Queiroz-Telles F, Esterre P, Perez-Blanco M, . Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol 2009; 47: 3–15.
   PubMed Web of Science ®Google Scholar
• Esterre P, Queiroz-Telles F. Management of chromoblastomycosis: novel perspectives Curr Opin Infect Dis 2006; 19: 148–152.
   PubMed Web of Science ®Google Scholar
• Najafzadeh MJ, Gueidan C, Badali H, . Genetic diversity and species delimitation in the opportunistic genus Fonsecaea. Med Mycol 2009; 47: 17–25.
   PubMed Web of Science ®Google Scholar
• Garnica M, Nucci M, Queiroz-Telles F. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis. Curr Opin Infect Dis 2009; 22: 559–563.
   PubMed Web of Science ®Google Scholar
• Santos ALS, Palmeira VF, Rozental S, . Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis. FEMS Microbiol Rev 2007; 31: 570–591.
   PubMed Web of Science ®Google Scholar
• Silva JP, de Souza W, Rozental S. Chromoblastomycosis: a retrospective study of 325 cases on Amazonic Region (Brazil). Mycopathologia 1998; 143: 171–175.
   PubMed Web of Science ®Google Scholar
• Mello e Silva ACC, Serra Neto A, Galvao CES, . [Fonsecaea pedrosoi-caused chromoblastomycosis in the state of Maranhao. I. The clinical, epidemiological and evolutionary aspects]. Rev Soc Bras Med Trop 1992; 25: 37–44.
   PubMedGoogle Scholar
• Marques SG, Silva CdMP, Saldanha PC, . Isolation of Fonsecaea pedrosoi from the shell of the Babassu coconut (Orbignya phalerata Martius) in the Amazon region of Maranhao Brazil. Japan J Med Mycol 2006; 47: 305–311.
   Google Scholar
• Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 2001; 44: 1–7.
   PubMed Web of Science ®Google Scholar
• Perez-Blanco M, Hernandez Valles R, Garcia-Humbria L, Yegres F. Chromoblastomycosis in children and adolescents in the endemic area of the Falcon State, Venezuela. Med Mycol 2006; 44: 467–471.
   PubMed Web of Science ®Google Scholar
• Brandt ME, Warnock DW. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother 2003; 15: 36–47.
   PubMed Web of Science ®Google Scholar
• Silveira F, Nucci M. Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis 2001; 14: 679–684.
   PubMed Web of Science ®Google Scholar
• Sudduth EJ, Crumbley AJ, III, Farrar WE. Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans. Clin Infect Dis 1992; 15: 639–644.
   PubMed Web of Science ®Google Scholar
• Clancy CJ, Wingard JR, Hong Nguyen M. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol 2000; 38: 169–175.
   PubMed Web of Science ®Google Scholar
• Padhye AA, Davis MS, Baer D, . Phaeohyphomycosis caused by Phaeoacremonium inflatipes. J Clin Microbiol 1998; 36: 2763–2765.
   PubMed Web of Science ®Google Scholar
• Marques SA, Camargo RMP, Summerbell RC, . Subcutaneous phaeohyphomycosis caused by Phaeoacremonium parasiticum in a renal transplant patient. Med Mycol 2006; 44: 671–676.
   PubMed Web of Science ®Google Scholar
• Sutton DA, Rinaldi MG, Kielhofner M. First U.S. report of subcutaneous phaeohyphomycosis caused by Veronaea botryosa in a heart transplant recipient and review of the literature. J Clin Microbiol 2004; 42: 2843–2846.
   PubMed Web of Science ®Google Scholar
• Burges GE, Walls CT, Maize JC. Subcutaneous phaeohyphomycosis caused by Exserohilum rostratum in an immunocompetent host. Arch Dermatol 1987; 123: 1346–1350.
   PubMedGoogle Scholar
• Castro LG, da Silva LC, Guarro J, . Phaeohyphomycotic cyst caused by Colletotrichum crassipes. J Clin Microbiol 2001; 39: 2321–2324.
   PubMed Web of Science ®Google Scholar
• Zaitz C, Heins-Vaccari EM, de Freitas RS, . Subcutaneous phaeohyphomycosis caused by Phoma cava. Report of a case and review of the literature. Rev Inst Med Trop Sao Paulo 1997; 39: 43–48.
   PubMedGoogle Scholar
• Ramos AMdO, Sales AdO, de Andrade MC, Bittencourt JF, Ramos CCF. A simple method for detecting subcutaneous phaeohyphomycosis with light-colored fungi. A study of eight cases. Am J Surg Pathol 1995; 19: 109–114.
   PubMed Web of Science ®Google Scholar
• Bambirra EA, Miranda D, Nogueira AMMF, Barbosa CSP. Phaeohyphomycotic cyst: a clinicopathologic study of the first four cases described from Brazil. Am J Trop Med Hyg 1983; 32: 794–798.
   PubMed Web of Science ®Google Scholar
• Campos-Takaki GM, Jardim ML. Report of chronic subcutaneous abscesses caused by Exophiala spinifera. Mycopathologia 1994; 127: 73–76.
   PubMed Web of Science ®Google Scholar
• Bittencourt AL, Machado PR, Araujo MG. Subcutaneous phaeohyphomycosis caused by Cyphellophora pluriseptata. Eur J Dermatol 2002; 12: 103–106.
   PubMed Web of Science ®Google Scholar
• Costa AR, Porto E, Tabuti AH, . Subcutaneous phaeohyphomycosis caused by Bipolaris hawaiiensis. A case report. Rev Inst Med Trop Sao Paulo 1991; 33: 74–79.
   PubMed Web of Science ®Google Scholar
• Silva MdRR, Fernandes OF, Costa CR, . Subcutaneoous phaeohyphomycosis by Exophiala jeanselmei in a cardiac transplant recipient Rev Inst Med Trop Sao Paulo 2005; 47: 55–57.
   PubMedGoogle Scholar
• Sabbaga E, Tedesco-Marchesi LM, Lacaz CS, . [Subcutaneous phaeohyphomycose due to Exophiala jeanselmi. Report of 3 cases in patients with a kidney transplant] Rev Inst Med Trop Sao Paulo 1994; 36: 175–183.
   PubMedGoogle Scholar
• Fernandes NC, Nacif D, Akiti T, Cuzzi T. Subcutaneous phaeohyphomycosis caused by Cladophialophora sp.: a case report. Rev Inst Med Trop Sao Paulo 2007; 49: 109–112.
   PubMedGoogle Scholar
• Padhye AA, Ajello L, Chandler FW, . Phaeohyphomycosis in El Salvador caused by Exophiala spinifera. Am J Trop Med Hyg 1983; 32: 799–803.
   PubMed Web of Science ®Google Scholar
• Mesa A, Henao J, Gil M, Durango G. Phaeohyphomycosis in kidney transplant patients. Clin Transplant 1999; 13: 273–276.
   PubMed Web of Science ®Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236–301.
   PubMed Web of Science ®Google Scholar
• Towersey L, Wanke B, Estrella RR, . Conidiobolus coronatus infection treated with ketoconazole. Arch Dermatol 1988; 124: 1392–1396.
   PubMedGoogle Scholar
• Jaramillo C, Tobon A, Franco L, Arango M, Restrepo A. Rinoentomoftoromicosis. presentacion de 3 casos. Medicina UPB 1996; 15: 135–142.
   Google Scholar
• Bittencourt AL, Serra G, Sadigursky M, . Subcutaneous zygomycosis caused by Basidiobolus haptosporus: presentation of a case mimicking Burkitt's lymphoma. Am J Trop Med Hyg 1982; 31: 370–373.
   PubMed Web of Science ®Google Scholar
• Bittencourt AL, Londero AT, AraujoMdS, Mendonca N, Bastos JLA. Occurrence of subcutaneous zygomycosis caused by Basidiobolus haptosporus in Brazil. Mycopathologia 1979; 68: 101–104.
   PubMed Web of Science ®Google Scholar
• Bittencourt AL, Araujo MdS, do Socorro Fontoura Paes M. Occurrence of subcutaneous zygomycosis (entomophthoromycosis basidiobolae) caused by Basidiobolus haptosporus with pulmonary involvement. Mycopathologia 1980; 71: 155–158.
   PubMed Web of Science ®Google Scholar
• Vianna LMdS, de Lacerda MV, de Moraes MAP. Case report of subcutaneous entomophthoromycosis with retroperitoneal invasion. Rev Soc Bras Med Trop 2005; 38: 348–350.
   PubMed Web of Science ®Google Scholar
• Costa AR, Porto E, Pegas JRP, . Rhinofacial zygomycosis caused by Conidiobolus coronatus. A case report. Mycopathologia 1991; 115: 1–8.
   PubMed Web of Science ®Google Scholar
• Tadano T, Paim NP, Hueb M, Fontes CJ. [Entomophthoramycosis (zygomycosis) caused by Conidiobolus coronatus in Mato Grosso (Brazil): case report]. Rev Soc Bras Med Trop 2005; 38: 188–190.
   PubMed Web of Science ®Google Scholar
• Costa AR, Porto E, Tayah M, . Subcutaneous mucormycosis caused by Mucor hiemalis Wehmer f. luteus (Linnemann) Schipper 1973. Mycoses 1990; 33: 241–246.
   PubMed Web of Science ®Google Scholar
• Telles Filho FdQ, Coelho A, Porto E, . Subcutaneous mucormycosis caused by Rhizopus oryzae probable nosocomial acquired infection Rev Inst Med Trop Sao Paulo 1985; 27: 201–206.
   PubMed Web of Science ®Google Scholar
• Taborda PR, Taborda VA, McGinnis MR. Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. J Clin Microbiol 1999; 37: 2031–2033.
   PubMed Web of Science ®Google Scholar
• Mendoza L, Belone AF, Vilela R, . Use of sera from humans and dolphins with lacaziosis and sera from experimentally infected mice for Western Blot analyses of Lacazia loboi antigens. Clin Vaccine Immunol 2008; 15: 164–167.
   PubMedGoogle Scholar
• Elsayed S, Kuhn SM, Barber D, . Human case of lobomycosis. Emerg Infect Dis 2004; 10: 715–718.
   PubMed Web of Science ®Google Scholar
• Burns RA, Roy JS, Woods C, Padhye AA, Warnock DW. Report of the first human case of lobomycosis in the United States. J Clin Microbiol 2000; 38: 1283–1285.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Toro G. Lobomycosis. Int J Dermatol 1993; 32: 324–332.
   PubMed Web of Science ®Google Scholar
• Paniz-Mondolfi AE, Reyes Jaimes O, Davila Jones L. Lobomycosis in Venezuela. Int J Dermatol 2007; 46: 180–185.
   PubMed Web of Science ®Google Scholar
• Baruzzi RG, Rodrigues DA, Michalany NS, Salomao R. Squamous-cell carcinoma and lobomycosis (Jorge Lobo's disease). Int J Dermatol 1989; 28: 183–185.
   PubMed Web of Science ®Google Scholar
• Talhari C, Oliveira CB, de Souza Santos MN, Ferreira LC, Talhari S. Disseminated lobomycosis. Int J Dermatol 2008; 47: 582–583.
   PubMed Web of Science ®Google Scholar
• Xavier MB, Ferreira MMR, Quaresma JAS, de Brito AC. HIV and lacaziosis, Brazil. Emerg Infect Dis 2006; 12: 526–527.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Toro G, Tellez N. Lobomycosis in Colombian Amer Indian patients. Mycopathologia 1992; 120: 5–9.
   PubMed Web of Science ®Google Scholar
• Kauffman CA, Bustamante B, Chapman SW, Pappas PG. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45: 1255–1265.
   PubMed Web of Science ®Google Scholar
• de Lima Barros MB, Schubach A, Francesconi-do-Valle AC, . Positive Montenegro skin test among patients with sporotrichosis in Rio de Janeiro. Acta Trop 2005; 93: 41–47.
   PubMed Web of Science ®Google Scholar
• Chapman SW, Pappas P, Kauffmann C, . Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses 2004; 47: 62–68.
   PubMed Web of Science ®Google Scholar
• Robledo P, Franco MA, Gomez RL, Restrepo MA. Tratamiento de la Esporotricosis con Itraconazol. Revista del Sociedade Col Dermatologia 1992; 1: 34–38
   Google Scholar
• Ahmed AAO, van de Sande WWJ, Fahal A, . Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 2007; 20: 146–151.
   PubMed Web of Science ®Google Scholar
• SP Europe. Noxafil 40 mg/ml oral suspension (summary of product characteristics). Brussels, Belgium, SP Europe, 2008.
   Google Scholar
• Garcia-Martos P, Marquez A, Gene J. [Human infections by black yeasts of genus Exophiala]. Rev Iberoam Micol 2002; 19: 72–79.
   PubMedGoogle Scholar
• Caligiorne RB, de Resende MA, Dias-Neto E, Oliveira SC, Azevedo V. Dematiaceous fungal pathogens: analysis of ribosomal DNA gene polymorphism by polymerase chain reaction-restriction fragment length polymorphism. Mycoses 1999; 42: 609–614.
   PubMed Web of Science ®Google Scholar
• Miranda MFR, Silva AJG. Vinyl adhesive tape also effective for direct microscopy diagnosis of chromomycosis, lobomycosis, and paracoccidioidomycosis. Diagn Microbiol Infect Dis 2005; 52: 39–43.
   PubMed Web of Science ®Google Scholar
• Oberto-Perdigon L, Romero H, Perez-Blanco M, Apitz-Castro R. [An ELISA test for the study of the therapeutic evolution of chromoblastomycosis by Cladophialophora carrionii in the endemic area of Falcon State, Venezuela – in Spanish]. Rev Iberoam Micol 2005; 22: 39–43.
   PubMedGoogle Scholar
• Bonifaz A, Paredes-Solis V, Saul A. Treating chromoblastomycosis with systemic antifungals. Exp Opin Pharmacother 2004; 5: 247–254.
   PubMed Web of Science ®Google Scholar
• Vartivarian SE, Anaissie EJ, Bodey GP. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin Infect Dis 1993; 17: S487–S491.
   PubMed Web of Science ®Google Scholar
• Fonseca JJS. Lobomycosis. IntJ Surg Pathol 2007; 15: 62–63.
   PubMed Web of Science ®Google Scholar
• Vitale RG, Perez-Blanco M, de Hoog GS. In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis. Med Mycol 2009; 47: 35–40.
   PubMed Web of Science ®Google Scholar
• McGinnis MR, Pasarell L. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J Clin Microbiol 1998; 36: 2353–2355.
   PubMed Web of Science ®Google Scholar
• Hamza SH, Mercado PJ, Skelton HG, Smith KJ. An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature. J Cutan Pathol 2003; 30: 340–343.
   PubMed Web of Science ®Google Scholar
• Marimon R, Serena C, Gene J, Cano J, Guarro J. In vitro antifungal susceptibilities of five species of Sporothrix. Antimicrob Agents Chemother 2008; 52: 732–734.
   PubMed Web of Science ®Google Scholar
• Alvarado-Ramirez E, Torres-Rodriguez JM. In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods. Antimicrob Agents Chemother 2007; 51: 2420–2423.
   PubMed Web of Science ®Google Scholar
• McGinnis MR, Nordoff N, Li RK, Pasarell L, Warnock DW. Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B. Med Mycol 2001; 39: 369–371.
   PubMed Web of Science ®Google Scholar
• Zeng J, Kamei K, Zheng Y, Nishimura K. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents. Japan J M Mycol 2004; 45: 101–104.
   Google Scholar
• Konishi M, Yonekawa S, Nakagawa C, . [Case of Scedosporium apiospermum cutaneous soft tissue infection treated with voriconazole]. J Japan Assoc Infect Dis 2008; 82: 82–85.
   PubMedGoogle Scholar
• Bosma F, Voss A, van Hamersvelt HW, . Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole. Clin Microbiol Infect 2003; 9: 750–753.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950–2956.
   PubMed Web of Science ®Google Scholar
• Negroni R, Tobon A, Bustamante B, . Posaconazole treatment of refractory eumycetoma and chromoblastomycosis Rev Inst Med Trop Sao Paulo 2005; 47: 339–346.
   PubMedGoogle Scholar
• Proia LA, Trenholme GM. Chronic refractory phaeohyphomycosis: successful treatment with posaconazole. Mycoses 2006; 49: 519–522.
   PubMed Web of Science ®Google Scholar
• Graybill JR, Najvar LK, Johnson E, Bocanegra R, Loebenberg D. Posaconazole therapy of disseminated phaeohyphomycosis in a murine model. Antimicrob Agents Chemother 2004; 48: 2288–2291.
   PubMed Web of Science ®Google Scholar
• Al-Abdely HM, Alkhunaizi A, Al-Tawfiq J, . Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med Mycol 2005; 43: 91–95.
   PubMed Web of Science ®Google Scholar
• Negroni R, Helou SH, Petri N, . Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera. Clin Infect Dis 2004; 38: 15–20.
   Web of Science ®Google Scholar
• Badali H, Najafzadeh MJ, van Esbroeck M, . The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species. Med Mycol 2010; 48: 318–327.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 2003; 20: 121–136.
   PubMedGoogle Scholar
• Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of Zygomycetes. Antimicrob Agents Chemother 2002; 46: 1581–1582.
   PubMed Web of Science ®Google Scholar
• Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 2007; 51: 2587–2590.
   PubMed Web of Science ®Google Scholar
• Chan Y, Goldwater P, Saxon B. Successful treatment of cutaneous and subcutaneous zygomycosis in an immunosuppressed patient with aplastic anaemia. J Paediatr Child Health 2007; 43: 87–89.
   PubMed Web of Science ®Google Scholar
• van Burik J-AH, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006; 42: e61–e65.
   PubMed Web of Science ®Google Scholar
• Nakai T, Uno J, Otomo K, . In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds. Chemotherapy 2002; 48: 78–81.
   PubMed Web of Science ®Google Scholar
• del Poeta M, Schell WA, Perfect JR. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob Agents Chemother 1997; 41: 1835–1836.
   PubMed Web of Science ®Google Scholar
• Singh J, Rimek D, Kappe R. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses 2005; 48: 246–250.
   PubMed Web of Science ®Google Scholar